openPR Logo
Press release

Regenerative Medicine Market Size and Share - Future Growth Expectations

10-25-2025 12:32 AM CET | Health & Medicine

Press release from: ABNewswire

The global regenerative medicine markets comprise of many key market players competing for markets shares like Novartis AG (Switzerland), Biogen, Inc. (US), Sarepta Therapeutics, Inc. (US)

The global regenerative medicine markets comprise of many key market players competing for markets shares like Novartis AG (Switzerland), Biogen, Inc. (US), Sarepta Therapeutics, Inc. (US)

Regenerative Medicine Market in terms of revenue was estimated to be worth $16.0 billion in 2023 and is poised to reach $49.0 billion by 2028, growing at a CAGR of 25.1% from 2023 to 2028 according to a new report by MarketsandMarkets Trademark .
Regenerative Medicine Market [https://www.marketsandmarkets.com/Market-Reports/regenerative-medicine-market-65442579.html] in terms of revenue was estimated to be worth $16.0 billion in 2023 and is poised to reach $49.0 billion by 2028, growing at a CAGR of 25.1% from 2023 to 2028 according to a new report by MarketsandMarkets Trademark . The important factors impacting market growth are the increasing focus on personalized medicine, and the emerging applications in new therapeutic areas. Increasing collaborations and partnerships by major market players and increasing regulatory approvals in regenerative medicine are expected to provide lucrative growth of the market in the near future.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579

Cell therapy segment accounted for the largest share of the regenerative medicine market

Based on product, the regenerative medicine market is segmented into gene therapy, cell therapy (stem cell therapy [cell transplantations, stem cell therapy products {Autologous stem cell therapy, allogenic stem cell therapy] cell-based immunotherapy products), and tissue engineering products. The cell therapy segment accounted for the largest share of the regenerative medicine market in 2022. The high adoption of stem cell therapy is a key contributor to the growth of this segment. The growing applications of hematopoietic stem cell transplantations (HSCT) are expected to drive the growth of the cell therapy market.

Musculoskeletal disorder wins the largest share of therapeutic areas

Based on therapeutic area, the regenerative medicine market is classified into oncology, neurology, musculoskeletal disorders, ophthalmology, cardiovascular diseases, dermatology & wound care and other applications. In 2022, the musculoskeletal disorders segment accounted for the largest share of the global regenerative medicine market. Rise in the orthopedic disorders prevalence along with increasing musculoskeletal regeneration research can be attributed to the rising growth rate of this segment.

During the forecast period, North America exhibited the most rapid growth.

The largest share of the global regenerative medicine market was of North America, closely followed by Europe and then the Asia Pacific. This can be accredited to the growth of stem cell research, healthcare sector expansion, and the increase in the adoption of stem cell therapy and cell immunotherapies for cancer and other chronic diseases treatment.

Regenerative Medicine Market Dynamics:

Drivers:

1. Focus on Personalized Medicine

Restraint:

1. Ethical and Legal concerns and high cost of regenerative medicines

Opportunities:

1. Harnessing the Potential of 3D Printing

Challenge:

1. Lack of favorable reimbursement policies across various regions

Key Market Players of Regenerative Medicine Industry:

The global regenerative medicine markets comprise of many key market players competing for markets shares like Novartis AG (Switzerland), Biogen, Inc. (US), Sarepta Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), Amgen Inc. (US), Smith+Nephew (UK), MEDIPOST Co., Ltd. (Korea), JCR Pharmaceuticals Co., Ltd. (Japan), Takeda Pharmaceutical Company Limited (Japan) and CORESTEM, Inc (South Korea).

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=65442579 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=65442579&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=regenerative-medicine-market-size-and-share-future-growth-expectations]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/regenerative-medicine-market-65442579.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Regenerative Medicine Market Size and Share - Future Growth Expectations here

News-ID: 4238790 • Views:

More Releases from ABNewswire

Windy City Chimney Heroes Announces Expanded Service Areas Across the Greater Chicago Region
Windy City Chimney Heroes Announces Expanded Service Areas Across the Greater Ch …
Windy City Chimney Heroes, a long-standing chimney company established in 1997, has expanded its service areas across the Greater Chicago region. The company now serves Chicago, Evanston, Oak Park, Naperville, Schaumburg, Cicero, Skokie, Berwyn, and Arlington Heights. Owner Wesley Cook says the expansion will help meet rising demand for reliable chimney repair and inspection services. Windy City Chimney Heroes, a trusted chimney repair and maintenance provider founded in 1997, has announced
Injury 2 Wellness Centers Promotes Wellness Care Through Ongoing Chiropractic Support
12-11-2025 | Sports
ABNewswire
Injury 2 Wellness Centers Promotes Wellness Care Through Ongoing Chiropractic Su …
As the year draws to a close and many individuals begin setting health goals for the new year, Injury 2 Wellness Centers is encouraging Georgia residents to prioritize wellness care through consistent chiropractic treatment. Far beyond addressing back or neck pain, chiropractic care can serve as a foundation for long-term physical health, improved function, and overall quality of life. Decatur, GA - December 10, 2025 - As the year draws to
Avalon Tree Services Reminds Atlanta Homeowners to Prioritize Winter Tree Care for Safety and Long-Term Health
Avalon Tree Services Reminds Atlanta Homeowners to Prioritize Winter Tree Care f …
As temperatures drop and trees enter their dormant season, Avalon Tree Services is reminding homeowners across Greater Atlanta that winter is one of the most important times to invest in proper tree care. Cold weather, ice accumulation, and seasonal storms can all take a toll on tree health and stability-making preventative maintenance essential for safety and long-term growth. Atlanta, GA - December 10, 2025 - As temperatures drop and trees enter
TrueProfit Shares 2026 Guidance for Shopify Startups to Focus on Profit First Not Launch Fast
TrueProfit Shares 2026 Guidance for Shopify Startups to Focus on Profit First No …
As Shopify heads into 2026 with millions of active stores worldwide and continued growth in global ecommerce, TrueProfit - a Net Profit Analytics platform for Shopify merchants - is urging new founders to treat profitability as a starting requirement, not an afterthought. With a low barrier to entry and a mature app ecosystem, Shopify remains one of the easiest ways to launch an online business. But TrueProfit's latest briefing on early-stage

All 5 Releases


More Releases for Novartis

Pazopanib Market Analysis By Top Keyplayers - Novartis, GlaxoSmithKline, Novarti …
The "Pazopanib Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Pazopanib Market, 2024-2031 Verified Market Research's most recent report, "Pazopanib Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the
Onychomycosis Market to Register Incremental Growth During the Forecast Period ( …
DelveInsight's "Onychomycosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Onychomycosis, historical and forecasted epidemiology as well as the Onychomycosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Onychomycosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Onychomycosis Market Forecast https://www.delveinsight.com/sample-request/onychomycosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key facts of the Onychomycosis
(2023-2031) Acromegaly Market | Novartis AG, Ipsen Pharma
[100 pages] Report "Acromegaly Market" detailed analysis of a business is mainly segmented by Application, by Type, Region (North America, Europe, Asia-Pacific, South America, and Middle East & Africa), manufacture and Forecast to 2031. "Final Report will add the analysis of the impact of COVID-19 on this industry." Global "Acromegaly Market" report analyses the best market prospects and lists the characteristics that are and will continue to propel the development of the
Rydapt Market 2020 Clinical Analysis – Novartis
Global Rydapt Market Growth 2020-2025 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Rydapt Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought
Global HER2-negative breast cancer Treatment Market to 2025| AstraZeneca, Bristo …
Researchmoz added Most up-to-date research on "Global HER2-negative breast cancer Treatment Market Size, Status and Forecast 2019-2025" to its huge collection of research reports. HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein. In 2018, the global HER2-negative breast cancer Treatment
Nilotinib Market Report 2018 – 2023: Novartis
The Study Paper in this Global Nilotinib Market includes Novartis. Get Free Sample Brochure of Nilotinib Market spread across [142 pages] @ https://www.marketgrowthinsight.com/sample/4896 Unbiased perspective on intangible aspects such as key challenges, threats, new entrants as well as strengths and weaknesses of the prominent vendors too are